How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

834 results for

Postpartum Office Visit

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

181. Guideline Supplement: Early onset Group B Streptococcal Disease

. In essence, you are free to copy and communicate the work in its current form for non-commercial purposes, as long as you attribute Queensland Clinical Guidelines, Queensland Health and abide by the licence terms. You may not alter or adapt the work in any way. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc- nd/3.0/au/deed.en For further information contact Queensland Clinical Guidelines, RBWH Post Office, Herston Qld 4029, email Guidelines@health.qld.gov.au, phone (07 (...) ) 3131 6777. For permissions beyond the scope of this licence contact: Intellectual Property Officer, Queensland Health, GPO Box 48, Brisbane Qld 4001, email ip_officer@health.qld.gov.au, phone (07) 3234 1479. Queensland Clinical Guideline Supplement: Early onset Group B Streptococcal disease Refer to online version, destroy printed copies after use Page 3 of 15 1 Introduction This document is a supplement to the Queensland Clinical Guideline Early onset Group B Streptococcal disease. It provides

2016 Queensland Health

182. Term small for gestational age baby

, you are free to copy and communicate the work in its current form for non-commercial purposes, as long as you attribute Queensland Clinical Guidelines, Queensland Health and abide by the licence terms. You may not alter or adapt the work in any way. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/3.0/au/deed.en For further information contact Queensland Clinical Guidelines, RBWH Post Office, Herston Qld 4029, email Guidelines@health.qld.gov.au, phone (07) 3131 (...) 6777. For permissions beyond the scope of this licence contact: Intellectual Property Officer, Queensland Health, GPO Box 48, Brisbane Qld 4001, email ip_officer@health.qld.gov.au, phone (07) 3234 1479. Queensland Clinical Guideline: Term small for gestational age baby Refer to online version, destroy printed copies after use Page 3 of 21 Flow Chart: Term small for gestational age baby No Yes/ potentially Initial care at birth: • Resuscitate and stabilise as required: o Perinatal asphyxia, meconium

2016 Queensland Health

183. Establishing breastfeeding

) • Postpartum assessment (clinical pathway, feeding) EBM unavailable? • Discuss options with mother, midwife and medical officer • Develop feeding plan Ongoing care • Assess breastfeeding • Initiate waking strategies as required • Monitor output/feeding patterns • Support mother to express as required • Refer as clinically indicated • Document progress Review and consider • Support for expressing • Giving EBM • Monitoring BGL • Continuing waking strategies • Developing/documenting a feeding plan • Seeking (...) of context, incomplete or unavailable. © State of Queensland (Queensland Health) 2016 This work is licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Australia. In essence, you are free to copy and communicate the work in its current form for non-commercial purposes, as long as you attribute Queensland Clinical Guidelines, Queensland Health and abide by the licence terms. You may not alter or adapt the work in any way. To view a copy of this licence, visit http

2016 Queensland Health

184. Perinatal substance use: maternal

No Derivatives 3.0 Australia licence. In essence, you are free to copy and communicate the work in its current form for non – commercial purposes, as long as you attribute Queensland Clinical Guidelines, Queensland Health and abide by the licence terms. You may not alter or adapt the work in any way. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/3.0/au/deed.en For further information contact Queensland Clinical Guidelines, RBWH Post Office, Herston Qld 4029, email (...) Guidelines@health.qld.gov.au, phone (07) 3131 6777. For permissions beyond the scope of this licence contact: Intellectual Property Officer, Queensland Health, GPO Box 48, Brisbane Qld 4001, email ip_officer@health.qld.gov.au, phone (07) 3234 1479. Queensland Clinical Guideline: Perinatal substance use: maternal Refer to online version, destroy printed copies after use Page 3 of 29 Flow Chart: Perinatal substance use management Resuscitation • Naloxone contraindicated in the neonatal period (including

2016 Queensland Health

185. Hypertensive disorders of pregnancy

are free to copy and communicate the work in its current form for non-commercial purposes, as long as you attribute Queensland Clinical Guidelines, Queensland Health and abide by the licence terms. You may not alter or adapt the work in any way. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc- nd/3.0/au/deed.en For further information contact Queensland Clinical Guidelines, RBWH Post Office, Herston Qld 4029, email Guidelines@health.qld.gov.au, phone (07) 3131 6777 (...) BP measurement • Correct measurement techniques are critical to the correct diagnosis of HDP 18 • Confirm non-severe hypertension by measuring BP over several hours o Up to 70% of women with an office BP of 140/90 mmHg have normal BP on subsequent measurements on the same visit 17 • Refer to Appendix A: Measurement of blood pressure Proteinuria • Screen women for proteinuria with urinary dipstick at each visit 17 1 • Quantify by laboratory methods if: o Greater than or equal to 2+ proteinuria

2016 Queensland Health

186. Guideline supplement: Term small for gestational age baby

3.0 Australia licence. In essence, you are free to copy and communicate the work in its current form for non-commercial purposes, as long as you attribute Queensland Clinical Guidelines, Queensland Health and abide by the licence terms. You may not alter or adapt the work in any way. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/3.0/au/deed.en For further information contact Queensland Clinical Guidelines, RBWH Post Office, Herston Qld 4029, email Guidelines (...) @health.qld.gov.au, phone (07) 3131 6777. For permissions beyond the scope of this licence contact: Intellectual Property Officer, Queensland Health, GPO Box 48, Brisbane Qld 4001, email ip_officer@health.qld.gov.au, phone (07) 3234 1479. Queensland Clinical Guideline Supplement: Term small for gestational age baby Refer to online version, destroy printed copies after use Page 3 of 11 1 Introduction This document is a supplement to the Queensland Clinical Guideline Term Small for gestational age baby

2016 Queensland Health

187. Diagnosis of Right Lower Quadrant Pain and Suspected Acute Appendicitis

. Transparency and stakeholder input are essential to the Effective Health Care Program. Please visit the Web site (www.effectivehealthcare.ahrq.gov) to see draft research questions and reports or to join an email list to learn about new program products and opportunities for input. If you have comments on this systematic review, they may be sent by mail to the Task Order Officer named below at: Agency for Healthcare Research and Quality, 5600 Fishers Lane, Rockville, MD 20857, or by email to epc (...) @ahrq.hhs.gov. Richard G. Kronick, Ph.D. Arlene S. Bierman, M.D., M.S. Director Director Agency for Healthcare Research and Quality Center for Evidence and Practice Improvement Agency for Healthcare Research and Quality Stephanie Chang, M.D., M.P.H. Elisabeth U. Kato, M.D., M.R.P. Director Task Order Officer Evidence-based Practice Center Program Center for Evidence and Practice Improvement Center for Evidence and Practice Improvement Agency for Healthcare Research and Quality Agency for Healthcare Research

2016 Effective Health Care Program (AHRQ)

188. Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations

on MSM and HIV (MSMGF), USA), Ruth Morgan Thomas (Global Network of Sex Work Projects (NSWP), United Kingdom), Debbie Muirhead (Department of Foreign Affairs and Trade (DFAT), Indonesia), Patrick Mutua Mburugu (Ministry of Public Health & Sanitation, Kenya), Ed Ngoksin (Global Network of People Living with HIV/ AIDS (GNP+), South Africa), Sam Nugraha # (Community Based Treatment (Rumah Singgah PEKA), Indonesia), Tonia Poteat (Office of the U.S. Global AIDS Coordinator (OGAC), USA), Ganesh (...) (The University of Hong Kong, China) and Tariq Zafar (Nai Zindagi, Pakistan). Representatives of UN agencies and other partners Jenny Butler (United Nations Population Fund, USA), Monica Ciupagea (United Nations Office on Drugs and Crime, Austria), Clifton Cortez (United Nations Development Programme Asia–Pacific Regional Centre, Thailand), Karl Dehne (Joint United Nations Programme on HIV/AIDS, Switzerland), Mauro Guarinieri (The Global Fund to Fight AIDS, Tuberculosis and Malaria, Switzerland), Fabienne

2016 World Health Organisation HIV Guidelines

189. Diabetes Prevention Programs

Review Karen K. Shore, PhD Partner, Transform Health Matt Seidner, BS Program Manager, Institute for Clinical and Economic Review Daniel A. Ollendorf, PhD Chief Scientific Officer, Institute for Clinical and Economic Review Jed Weissberg, MD Senior Fellow, Institute for Clinical and Economic Review Steven D. Pearson, MD, MSc President, Institute for Clinical and Economic Review DATE OF PUBLICATION: June 6, 2016 We would also like to thank Erin Lawler and Anne Loos for their contributions (...) , and health industry manufacturers. For a complete list of funders, visit http://www.icer- review.org/about/support/. Through all its work, ICER seeks to help create a future in which collaborative efforts to move evidence into action provide the foundation for a more effective, efficient, and just health care system. More information about ICER is available at http://www.icer- review.org About CTAF The California Technology Assessment Forum (CTAF) – a core program of ICER – provides a public venue

2016 California Technology Assessment Forum

190. Collaboration in Practice: Implementing Team-Based Care

Medicare beneficiary visits two primary care providers and five specialists per year, as well as health care providers of diagnostic, pharmacy, and other services. This figure is several times larger for x Introduction people with multiple chronic conditions (4). In order to manage large amounts of information and multiple handoffs, seamless communication and transitions among health care providers (within a team or among teams) are required to support wellness and care for patients with complex health (...) , supplemented by review of the patient’s medical record available through the health information exchange, the PA finds that the woman has not been adhering correctly to her prescription intended to prevent gout attacks. The PA counsels the patient and her husband, prescribes an anti-inflammatory and pain medication, and recommends that the patient follow up with her primary care provider. The PA provides the patient with a summary of findings from the visit for reference during her follow-up visit

2016 American College of Obstetricians and Gynecologists

191. Depression

effect profile, presence of medical and psychiatric co- morbidity, and prior response [IIA*]. Relative costs can also be considered because of the large selection of antidepressants available in generic form. Patients treated with antidepressants should be closely observed for possible worsening of depression or suicidality, especially at the beginning of therapy or when the dose increases or decreases [IC*]. • Frequent initial visits. Patients require frequent visits early in treatment to assess (...) . Sleep disturbance, either with initiation or maintenance of sleep Medical visits. Frequent, often unscheduled, patient-initiated visits to the physician or the emergency room for unclear reasons "Difficult". Patients labeled by the physician as “difficult” or a “problem”, as well as a sense of dysphoria by the physician when seeing the patient Dysfunction. Patients who have cognitive or emotional dysfunction i.e., forgetfulness, irritability and loss of motivation or energy Recurrence. Past history

2016 University of Michigan Health System

192. Daily iron supplementation in adult women and adolescent girls

iron a SUPPLEMENT FORM Tablets FREQUENCY Daily DURATION Three consecutive months in a year SETTINGS Where the prevalence of anaemia in menstruating adult women and adolescent girls is 40% or higher b a 30–60 mg of elemental iron equals 150–300 mg of ferrous sulfate heptahydrate, 90–180 mg of ferrous fumarate or 250–500 mg of ferrous gluconate. b In the absence of prevalence data in this group, consider proxies for high risk of anaemia. For the most recent estimates, visit the WHO - hosted Vitamin (...) iron and folic acid supplementation should be part of routine antenatal care, begun as early as possible and continued throughout pregnancy. Where the prevalence of anaemia in pregnant women is high (40% or more), supplementation should continue for 3 months in the postpartum period (10, 11). Research priorities Discussions between the members of the WHO guideline development group and the external review group highlighted the limited evidence available in some knowledge areas, meriting further

2016 World Health Organisation Guidelines

193. Establishing breastfeeding

) • Postpartum assessment (clinical pathway, feeding) EBM unavailable? • Discuss options with mother, midwife and medical officer • Develop feeding plan Ongoing care • Assess breastfeeding • Initiate waking strategies as required • Monitor output/feeding patterns • Support mother to express as required • Refer as clinically indicated • Document progress Review and consider • Support for expressing • Giving EBM • Monitoring BGL • Continuing waking strategies • Developing/documenting a feeding plan • Seeking (...) of context, incomplete or unavailable. © State of Queensland (Queensland Health) 2016 This work is licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Australia. In essence, you are free to copy and communicate the work in its current form for non-commercial purposes, as long as you attribute Queensland Clinical Guidelines, Queensland Health and abide by the licence terms. You may not alter or adapt the work in any way. To view a copy of this licence, visit http

2016 Clinical Practice Guidelines Portal

194. Guidelines for the management of screen-detected abnormalities, screening in specific populations and investigation of abnormal vaginal bleeding

use as permitted under the Copyright act 1968, no part may be reproduced by any process without prior written permission from Cancer Council australia. requests and enquiries concerning reproduction and rights should be addressed to the Copyright officer: Cancer Council australia gPo box 4708 Sydney NSW 2001 australia www.cancer.org.au info@cancer.org.au Disclaimer this document is a general guide to appropriate practice, to be followed subject to the clinician’s judgment and the patient’s (...) with a positive oncogenic HPV (not 16/18) test result (self-collected sample) Women who have undergone hPv testing on a self-collected sample and who have a positive oncogenic hPv (not 16/18) test result should be advised to visit their gP or healthcare professional to obtain a cervical sample for lbC: • If the LBC test result is negative or pLSIL/LSIL, HPV testing should be repeated in 12 months, preferably by a healthcare professional. • If the LBC test result is pHSIL/HSIL or any glandular abnormality

2016 Cancer Council Australia

195. American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for Comprehensive Medical Care of Patients with Obesity

correspondence to American Association of Clinical Endocrinologists, 245 Riverside Ave, Suite 200, Jacksonville, FL 32202. E-mail: publications@aace.com. DOI:10.4158/EP161365.GL To purchase reprints of this article, please visit: www.aace.com/reprints. Copyright © 2016 AACE. *A complete list of the Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines can be found in the Acknowledgement.2 AACE/ACE Obesity CPG, Endocr Pract. 2016;22(Suppl 3) Table of Contents: Appendix Introduction and Executive

2016 American Association of Clinical Endocrinologists

197. Antenatal care - uncomplicated pregnancy

have been updated in line with the Department of Health publication Alcohol Guidelines Review - report from the Guidelines development group to the UK Chief Medical Officers (2016). April to May 2016 — reviewed. A literature search was conducted in April 2016 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials (RCTs) published since the last revision of the topic. No major changes to clinical recommendations have been made. Previous changes (...) caesarean section, myomectomy, or cone biopsy. Antenatal or postpartum haemorrhage on two or more occasions. Retained placenta on two or more occasions. Puerperal psychosis. Grand multiparity (having previously delivered 5 or more infants who achieved a gestational age of at least 24 weeks). Stillbirth or neonatal death. A small-for-gestational-age infant (less than fifth percentile). A large-for-gestational-age infant (greater than 95th percentile). An infant weighing less than 2,500 g or more than

2019 NICE Clinical Knowledge Summaries

198. Smoking: acute, maternity and mental health services

recommendation 6). Offer and, if the person agrees, arrange for them to receive intensive behavioural support, either during their current outpatient visit or during their inpatient stay (see Smoking: acute, maternity and mental health services (PH48) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 9 of 66recommendations 3 and 4). For people using secondary care services in a community setting, staff who are trained (...) . This includes partners, parents, other family members and carers. People who use or visit acute, maternity and mental health settings. Who should tak Who should take action? e action? Health and social care practitioners in acute, maternity and mental health services. Stop smoking advisers. What action should they tak What action should they take? e? During contact with partners, parents, other household members and carers of people using acute, maternity and mental health services: provide clear

2013 National Institute for Health and Clinical Excellence - Clinical Guidelines

199. Clinic-Based Programs to Prevent Repeat Teen Pregnancy: A Systematic Review

. Four studies found positive (n=2) or null (n=2) effects on repeat teen pregnancy prevention; an additional study described facilitators for helping teen mothers remain linked to services.This review identified clinic-based repeat teen pregnancy prevention programs and few positively affect factors that may reduce repeat teen pregnancy. Access to immediate postpartum contraception or home visiting programs may be opportunities to meet adolescents where they are and reduce repeat teen pregnancy.This (...) article is part of a theme issue entitled Updating the Systematic Reviews Used to Develop the U.S. Recommendations for Providing Quality Family Planning Services, which is sponsored by the Office of Population Affairs, U.S. Department of Health and Human Services.Copyright © 2018. Published by Elsevier Inc.

2018 EvidenceUpdates

200. Social and emotional wellbeing: early years

Introduction: scope and purpose of this guidance 7 What is this guidance about? 7 Who is this guidance for? 7 Why is this guidance being produced? 7 How was this guidance developed? 8 What evidence is the guidance based on? 8 Status of this guidance 8 1 Recommendations 9 Background: social and emotional development 9 Home visiting, early education and childcare 9 Whose health will benefit? 10 Recommendation 1 Strategy, commissioning and review 10 Recommendation 2 Identifying vulnerable children (...) and assessing their needs 11 Recommendation 3 Antenatal and postnatal home visiting for vulnerable children and their families 13 Recommendation 4 Early education and childcare 15 Recommendation 5 Delivering services 16 2 Public health need and practice 18 Policy 18 Benefits of social and emotional wellbeing 19 Factors that impact on social and emotional wellbeing 19 Current services 19 Costs 20 3 Considerations 21 4 Implementation 25 5 Recommendations for research 27 Social and emotional wellbeing: early

2012 National Institute for Health and Clinical Excellence - Clinical Guidelines

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>